Evidence map›Paper›PMID 35172563›Full record

Trial reportHaematologica2022

Outstanding outcomes in infants with

Erin M Guest, John A Kairalla, Joanne M Hilden, ZoAnn E Dreyer, Andrew J Carroll, Nyla A Heerema, Cindy Y Wang, Meenakshi Devidas, Lia Gore, Wanda L Salzer and 7 more

Abstract readClinical Trial
In one paragraph

Trial report in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. International journal of molecular sciences · 2024
    Review
  3. Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Updates inBiomedicines · 2023
    Review
  7. Article
  8. Updates in infant acute lymphoblastic leukemia and the potential for targeted therapy.Hematology. American Society of Hematology. Education Program · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Erin M GuestDivision of Hematology/Oncology/Blood and Marrow Transplantation, Children's Mercy Kansas City, Kansas City, MO. eguest@cmh.edu.
John A KairallaDepartment of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL.
Joanne M HildenCenter for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO.
ZoAnn E DreyerTexas Children's Hospital, Houston, TX.
Andrew J CarrollDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL.
Nyla A HeeremaThe Ohio State University Comprehensive Cancer Center, Columbus, OH.
Cindy Y WangDepartment of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL.
Meenakshi DevidasDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN.
Lia GoreCenter for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO.
Wanda L SalzerU.S. Army Medical Research and Materiel Command, Fort Detrick, MD.
Naomi J WinickDivision of Pediatric Hematology/Oncology, University of Texas Southwestern School of Medicine, Dallas, TX.
William L CarrollDepartment of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY.
Elizabeth A RaetzDepartment of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY.
Michael BorowitzDepartments of Pathology and Oncology, Johns Hopkins University, Baltimore, MD.
Mignon L LohDepartment of Pediatrics, Benioff Children's Hospital in the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.
Stephen P HungerDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Patrick A BrownDivision of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG FOREIGN ACCRUALU10CA098543 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI ADAMSON, PETER C. · 2003 to 2013
$335.5M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Children's Oncology Group Statistics &Data Center GrantU10CA098413 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DEVIDAS, MEENAKSHI · 2003 to 2013
$67.5M
NCI NIH HHS U10 CA098413NCI NIH HHS U10 CA098543NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myeloid-Lymphoid Leukemia ProteinPrecursor Cell Lymphoblastic Leukemia-LymphomaClinical Trials as TopicGerm CellsHumansInfantTreatment OutcomeMyeloid-Lymphoid Leukemia Protein

Identifiers

PMID35172563
PMCPMC9052896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.